Respiratory Vaccine Playbook 2026-2027: Updated Guidance and Strategies to Improve Patient Uptake
Respiratory vaccines are a fast and easy way to safeguard patient health, and pharmacy professionals are uniquely well-positioned to help improve vaccination rates. In this updated and enhanced playbook, participants will gain practical guidance on influenza, COVID-19, RSV, and pneumococcal vaccines. Through focused micro-learning modules, you’ll gain actionable strategies to improve vaccine uptake, address patient hesitancy, and deliver evidence-based care.
$0.00
Description
Description:
As the pharmacy landscape continues to evolve, this updated and enhanced playbook provides the latest information on respiratory health and vaccinations to help pharmacy professionals make informed, evidence-based decisions and deliver quality patient care. With multiple vaccines available for influenza, COVID-19, respiratory syncytial virus (RSV), and pneumococcal disease, staying current with evolving recommendations is essential. This relaunch features updated content, expanded guidance, and current information on respiratory vaccination recommendations and patient eligibility.
This interactive micro-learning program breaks down complex recommendations into clear, actionable steps. You’ll learn to identify eligible patients, navigate vaccine scheduling, and co-administration, and address contraindications and safety considerations. The content also provides practical strategies for communicating effectively with patients, including those who may be hesitant or uncertain about vaccination.
Designed for busy pharmacy practice, each focused module delivers practical, evidence-based knowledge that can be applied in real-world scenarios. Whether refreshing your knowledge or exploring the latest recommendations, this course will help you stay informed, strengthen your confidence in vaccination decisions, and support increased vaccine uptake in your community.
Learning Objectives:
Upon successful completion of this continuing education activity, participants will be better able to:
- Identify patients for influenza, COVID 19, RSV, and pneumococcal vaccination based on current NACI recommendations.
- Select and schedule the most appropriate respiratory vaccine(s) and dose timing for patients.
- Counsel patients confidently on vaccine safety, effectiveness, and common concerns using collaborative communication techniques.
- Address frequently asked questions regarding common respiratory vaccines.
Course Outline:
The course includes a total of 5 modules, designed for self-directed learning. Note that you will receive CEUs and a letter of completion for every module you successfully complete.
-
Learning modules
-
Foundations of Respiratory Vaccination & Influenza – 30 minutes
-
COVID-19 – 30 minutes
-
Respiratory Syncytial Virus (RSV) – 20 minutes
-
Pneumococcus – 15 minutes
-
Collaborative Communication and Clinical Pearls for Effective Practice – 15 minutes
-
Multiple choice exam at the end of each module
-
Program evaluation
Sponsor(s):
This program is developed by the author in collaboration with the Ontario Pharmacists Association and supported by an education grant from Pfizer Canada ULC. It is intended for health care professionals only.
Course at a Glance:
Who Should Take This Course:
This course is intended for pharmacists. This course is also open to healthcare providers who are interested in and would benefit from the content of this program.
Author:
Our Commitment:
OPA is committed to providing high-quality, accurate, and unbiased educational content, tools, and resources for healthcare professionals and patients. Learn more about our process for content development and what it means to be a CCCEP accredited provider here.
Cancellation Policy:
Please refer to OPA’s Terms and Conditions of Purchase for cancellation policies.
